Editorial
doi: 10.1001/jama.2017.2725.
Reevaluating Postnatal Steroids for Extremely Preterm Infants to Prevent Lung Disease
Affiliations
- PMID: 28384808
- DOI: 10.1001/jama.2017.2725
Item in Clipboard
Editorial
Reevaluating Postnatal Steroids for Extremely Preterm Infants to Prevent Lung Disease
JAMA.
.
Free article
No abstract available
Comment on
-
Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.JAMA. 2017 Apr 4;317(13):1329-1337. doi: 10.1001/jama.2017.2692. JAMA. 2017. PMID: 28384828 Clinical Trial.
Similar articles
-
Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.Cochrane Database Syst Rev. 2001;(2):CD001145. doi: 10.1002/14651858.CD001145. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2003;(1):CD001145. doi: 10.1002/14651858.CD001145 PMID: 11405975 Updated. Review.
-
Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants.Cochrane Database Syst Rev. 2009 Jan 21;(1):CD001145. doi: 10.1002/14651858.CD001145.pub2. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2014 May 13;(5):CD001145. doi: 10.1002/14651858.CD001145.pub3 PMID: 19160189 Updated. Review.
-
Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants.Cochrane Database Syst Rev. 2014 May 13;(5):CD001145. doi: 10.1002/14651858.CD001145.pub3. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2017 Oct 24;10:CD001145. doi: 10.1002/14651858.CD001145.pub4 PMID: 24825542 Updated. Review.
-
Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.Cochrane Database Syst Rev. 2000;(2):CD001145. doi: 10.1002/14651858.CD001145. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2001;(2):CD001145. doi: 10.1002/14651858.CD001145 PMID: 10796251 Updated. Review.
-
Postnatal steroids to treat or prevent chronic lung disease in preterm infants.Pediatrics. 2003 Jan;111(1):221-2; author reply 221-2. doi: 10.1542/peds.111.1.221. Pediatrics. 2003. PMID: 12509584 No abstract available.
Cited by
-
Benefits and obstacles to cell therapy in neonates: The INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research).Stem Cells Transl Med. 2021 Jul;10(7):968-975. doi: 10.1002/sctm.20-0508. Epub 2021 Feb 11. Stem Cells Transl Med. 2021. PMID: 33570257 Free PMC article. Review.
-
Retinopathy of prematurity: a review of risk factors and their clinical significance.Surv Ophthalmol. 2018 Sep-Oct;63(5):618-637. doi: 10.1016/j.survophthal.2018.04.002. Epub 2018 Apr 19. Surv Ophthalmol. 2018. PMID: 29679617 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
